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Styrene oligomers—such as trans-1,2-
diphenylcyclobutane (TCB), cis-1,2-diphenyl-
cyclobutane (CCB), 1,3-diphenylpropane,
2,4-diphenyl-1-butene, 2,4,6-triphenyl-1-
hexene, and 1α-phenyl-4β-(1´-phenyl-
ethyl)tetralin—are incorporated into
polystyrene resin as impurities in the course of
manufacture and may have a variety of bio-
logic actions, including hormonal activity
(Kawamura et al. 1998b, 1998c). Polystyrene
has been used to manufacture food containers
for takeout, such as coffee cups, meat trays,
salad boxes, and soup bowls, as well as con-
tainers in which instant foods such as noodles,
pasta, and rice are cooked by adding hot
water. Some reports indicate that styrene
oligomers migrate from these containers into
the food contents (Kawamura et al. 1998b;
Sakamoto et al. 2000). Kawamura et al.
(1998b) reported that the quantity of
migrated styrene trimers was higher than that
of bisphenol A transferred from the lacquer
coating of vegetable cans to the food contents,
as reported by Brotons et al. (1995).
Some manmade compounds mimic the
effect of estradiol; they include chlorinated
organics, such as the insecticides kepone, o,p´-
DDT (o,p´-dichlorodiphenyltrichloroethane),
p,p´-DDD (p,p´-dichlorodiphenyldichloro-
ethane), and dieldrin and some polychlorinated
biphenyl congeners, as well as nonchlorinated
compounds such as the plasticizer bisphenol A
and the surfactant breakdown product
nonylphenol (Colborn 1995; Andersen et al.
1999). Such compounds can accumulate in our
environment, and these so-called environmen-
tal estrogens may play a role in the increasing
incidence of breast cancer, testicular cancer,
and other problems of the reproductive system.
Quantitative structure–activity relationship
work on the structural features of estrogen
receptor ligands shows that an unhindered
hydroxyl group on an aryl ring and a
hydrophobic group attached para to the
hydroxyl group are essential (Anstead et al.
1997; Fang et al. 2000; Shi et al. 2001; Hong
et al. 2002). The ligand binding assay and stud-
ies in a reporter/transcriptional system for the
estrogen receptor support the requirement for
these structural features (Nishihara et al. 2000;
Blair et al. 2000; Branham et al. 2002).
Recently, we showed that trans-stilbene, the
parent compound of diethylstilbestrol, was not
estrogenic but exhibited a potent estrogenic
activity after metabolic activation by a liver
microsomal oxidation system (Sugihara et al.
2000). In that report, we suggested that the
estrogenic activity of trans-stilbene was caused
by hydroxylated metabolites. TCB, a styrene
dimer, may also be converted to an estrogen by
metabolic activation, based on the similarity of
its structure to that of trans-stilbene.
For this report, we examined the estrogenic
activities of styrene oligomers in the presence or
absence of a liver microsomal metabolic system
using a yeast estrogen screening (YES) assay
and an estrogen-responsive element (ERE)-
luciferase reporter assay in the estrogen-respon-
sive human breast cancer cell line MCF-7. We
examined TCB, CCB, 1,3-diphenylpropane,
2,4-diphenyl-1-butene, 2,4,6-triphenyl-1-hex-
ene, and 1α-phenyl-4β-(1´-phenylethyl)tetralin
in this study (Figure 1). We found that some
styrene oligomers, especially TCB, exhibit sig-
niﬁcant estrogenic activities after activation by
rat liver microsomal mixed function oxidase.
Materials and Methods
Chemicals. TCB (99.3%), CCB (99.9%),
1,3-diphenylpropane (98.1%), 2,4-diphenyl-
1-butene (96.1%), 2,4,6-triphenyl-1-hexene
(99.4%), and 1α-phenyl-4β-(1´-phenyl-
ethyl)tetralin (99.1%) were obtained from
Kanto Chemical Co. Inc. (Tokyo, Japan),
and 17β-estradiol (E2; > 98%) and tamox-
ifen (> 99%) from Sigma Chemical Co. (St.
Louis, MO, USA). Chlorophenol red β-D-
galactopyranoside (CPRG) was obtained
from Roche Diagnostics (Mannheim,
Germany). We obtained trans-1,2-bis-(4-
hydroxyphenyl)cyclobutane (96%) by
isomerization of cis-1,2-bis-(4-hydroxy-
phenyl)cyclobutane by the method of
Williard and Fryhle (1980), and synthesized
cis-1,2-bis-(4-hydroxyphenyl)cyclobutane
according to the method of Brown (1968).
Animals. Male Sprague-Dawley rats
(190–220 g) were obtained from Japan SLC,
Inc. (Shizuoka, Japan). The animals were
housed at 22°C with a 12-hr light/dark cycle,
with free access to tap water and a standard
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In this study we examined estrogenic activity of styrene oligomers after metabolic activation by rat
liver microsomes. trans-1,2-Diphenylcyclobutane (TCB), cis-1,2-diphenylcyclobutane (CCB), 1,3-
diphenylpropane, 2,4-diphenyl-1-butene, 2,4,6-triphenyl-1-hexene, and 1α-phenyl-4β-(1´-
phenylethyl)tetralin were negative in the yeast estrogen screening assay and estrogen reporter assay
using estrogen-responsive human breast cancer cell line MCF-7. However, TCB exhibited estro-
genic activity after incubation with liver microsomes of phenobarbital-treated rats in the presence
of reduced nicotinamide adenine dinucleotide phosphate (NADPH). Minor activity was observed
when liver microsomes of untreated or 3-methylcholanthrene–treated rats were used instead of
those from phenobarbital-treated rats. CCB, 1,3-diphenylpropane, and 2,4-diphenyl-1-butene also
exhibited estrogenic activity after metabolic activation by liver microsomes, but the activity was
lower than that of TCB. 2,4,6-Triphenyl-1-hexene and 1α-phenyl-4β-(1´-phenylethyl)tetralin did
not show estrogenic activity after such incubation. When TCB was incubated with liver micro-
somes of phenobarbital-treated rats in the presence of NADPH, three metabolites were detected
by high-performance liquid chromatography (HPLC). One metabolite isolated by HPLC exhib-
ited a signiﬁcant estrogenic activity. The active metabolite was identiﬁed as trans-1-(4-hydroxy-
phenyl)-2-phenylcyclobutane by mass and nuclear magnetic resonance spectral analysis. These
results suggest that the estrogenic activity of TCB was caused by the formation of the 4-hydroxy-
lated metabolite. Key words: trans-1,2-diphenylcyclobutane, endocrine disruption, estrogenic
activity, human breast cancer cell line MCF-7, metabolic activation, rat liver microsomes, styrene
oligomer, yeast estrogen screening assay. Environ Health Perspect 111:329–334 (2003).
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Research | Articlespellet diet (MM-3; Funabashi Farm, Funabashi,
Japan). In some experiments, rats were given
intraperitoneal administration of phenobarbi-
tal (80 mg/kg) or 3-methylcholanthrene (25
mg/kg) daily for 3 days before use.
Preparation of liver microsomes. The livers
were excised from exsanguinated rats and
immediately perfused with 1.15% KCl. The
livers were homogenized in four volumes of the
KCl solution using a Potter-Elvehjem homoge-
nizer (Iwaki Glass Co., Ltd., Tokyo, Japan).
The microsomal fraction was obtained from
the homogenate by successive centrifugation at
9,000 × g for 20 min and 105,000 × g for 60
min. The fraction was washed by resuspension
in the KCl solution and resedimentation. The
pellets of microsomes were resuspended in the
solution to make 1 mL equivalent to 1 g of
liver. Protein contents in the liver microsomal
preparation of untreated, phenobarbital-
treated, and 3-methylcholanthrene–treated rats
were 13.7–17.6, 13.9–15.4, and 6.18–8.16 mg
protein/mL, respectively, as determined by the
method of Lowry et al. (1951).
Cell culture. MCF-7 cell lines were main-
tained in minimum essential medium (MEM;
Sigma Chemical Co.) containing penicillin
and streptomycin with 5% fetal bovine serum
(Life Technologies, Rockville, MD, USA).
Assay of estrogenic activities of styrene
oligomers in recombinant yeast. For the YES
assay, a recombinant yeast strain transfected
with the human estrogen receptor (ERα)
gene and expression plasmids carrying the
reporter gene lac-Z preceded by ERE were
kindly provided by J. Sumpter (Brunel
University, Uxbridge, Middlesex, UK). The
yeast estrogenicity assay was conducted as
described by Routledge and Sumpter (1996,
1997), with some minor modifications
(Yoshihara et al. 2001). In brief, a styrene
oligomer in yeast assay medium containing
recombinant yeast and CPRG, a chro-
mogenic substrate of the β-galactosidase
reporter enzyme, was dispensed into 96-well
plastic microtiter plates. The plates were
incubated at 32°C. After 24–48 hr, the
absorbance of the red color due to the hydrol-
ysis product of CPRG was read using a
microplate reader (Model 550; Bio-Rad
Laboratories, Hercules, CA, USA) at 540 nm.
The data were corrected for turbidity based
on the absorbance at 620 nm (optical density,
OD620), and the values were calculated as fol-
lows: Net OD540 = (OD540 for test – OD620
for test) – (OD540 for blank – OD620 for
blank). For the assay of the metabolites
produced from styrene oligomers, substrates
(0.1 µmol) were incubated with 0.1 mL of rat
liver microsomes in the presence of 1 µmol of
reduced nicotinamide adenine dinucleotide
phosphate (NADPH) for 30 min in a final
volume of 1 mL of 0.1 M phosphate buffer.
After the incubation, the mixture was
extracted with 5 mL of ethyl acetate and the
organic solution was evaporated to dryness.
The residue was dissolved with 1 mL of
ethanol and an aliquot was used for the estro-
genic activity assay. The total concentration
of the substrate and its metabolites was calcu-
lated from the original amount of the sub-
strate. In some experiments, tamoxifen was
added at the concentration of 1 × 10–8 M to
wells as an antiestrogen.
Assay of estrogenic activities of styrene
oligomers in MCF-7 cells. For ERE–luciferase
reporter assay using MCF-7 cells, the culture
medium was changed to phenol red–free
MEM (Sigma Chemical Co.) containing peni-
cillin, streptomycin, and dextran–charcoal-
treated fetal bovine serum for 2–3 days.
Transient transfections of MCF-7 cells were
performed with Transfast (Promega Co.,
Madison, WI, USA), using the manufacturer’s
protocol. Transfections were done in 12-well
plates at 1 × 105 cells/well with 1.9 µg
p(ERE)3-SV40-luc and 0.1 µg pRL/CMV
(Promega Co.) as an internal standard.
Twenty-four hours after addition of the sample
(ﬁnal concentration, 10–4 to 10–9 M) dissolved
in 10 µL ethanol, the assay was performed with
a Dual Luciferase assay kit (Promega Co.)
according to the manufacturer’s protocol. For
assay after incubation of chemicals with the rat
liver microsomal enzyme system, a sample from
the incubation mixture was subjected to the
assay as described above.
Isolation of TCB metabolites from the
incubation mixture of rat liver microsomes.
The incubation mixture consisted of 12 µmol
TCB, 30 µmol NADPH, and 1.2 mL liver
microsomes equivalent to 1.2 g liver (wet
weight) in a ﬁnal volume of 20 mL of 0.1 M
phosphate buffer (pH 7.4). The incubation
was performed at 37°C for 30 min. Then, the
mixture was extracted twice with two volumes
of ethyl acetate. The combined extract was
dried over anhydrous Na2SO4 and evaporated
to dryness in vacuo. A metabolite of TCB with
estrogenic activity was puriﬁed by preparative
high-performance liquid chromatography
(HPLC).
Assay of TCB oxidase activity. An incuba-
tion mixture consisted of 0.1 µmol TCB,
0.5 µmol NADPH, and 0.02 mL liver micro-
somes equivalent to 20 mg liver wet weight
(0.2–0.3 mg protein) in a final volume of
1 mL 0.1 M K,Na-phosphate buffer (pH 7.4).
The incubation was performed at 37°C for
5 min. After incubation, 0.1 µmol trans-stil-
bene oxide as an internal standard was added,
and the mixture was extracted with 5 mL ethyl
acetate. The extract was evaporated to dryness,
the residue was dissolved in 0.1 mL methanol,
and an aliquot (5 µL) was analyzed by HPLC.
HPLC and thin-layer chromatography.
HPLC was performed in a Hitachi L-6000
chromatograph (Tokyo, Japan) ﬁtted with a
150 × 4.6 mm Inertsil ODS-3 column (GL
Science, Tokyo, Japan). The mobile phase
was acetonitrile–water (6:4, vol/vol). The
chromatograph was operated at a flow rate
of 0.5 mL/min at a wavelength of 240 nm.
The elution times of trans-1-(4-hydroxy-
phenyl)-2-phenylcyclobutane, TCB, CCB,
and trans-stilbene oxide (an internal stan-
dard) were 14.6, 68.0, 55.3, and 25.2 min,
respectively. For the detection of trans-1,2-
bis-(4-hydroxyphenyl)cyclobutane, the
mobile phase was acetonitrile–water (3:7,
vol/vol). The chromatograph was operated
at a ﬂow rate of 0.5 mL/min at a wavelength
of 240 nm. The elution time of trans-1,2-
bis-(4-hydroxyphenyl)cyclobutane was
12.2 min.
Silica gel plates (Kieselgel 60 GF254,
0.1 mm thick; Merck, Darmstadt, Germany)
were developed in n-hexane–ethyl acetate
(9:1, vol/vol). Spots were visualized under
ultraviolet light (254 nm). The Rf (rate of
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Figure 1. Structures of styrene oligomers.
trans-1,2-Diphenylcyclobutane cis-1,2-Diphenylcyclobutane 1-Phenyl-4-
(1’-phenylethyl)tetralin
1,3-Diphenylpropane
2,4,6-Triphenyl-1-hexene
2,4-Diphenyl-1-buteneflow) values of TCB, trans-1-(4-hydroxy-
phenyl)-2-phenylcyclobutane, and trans-1,2-
bis-(4-hydroxyphenyl)cyclobutane were 0.78,
0.44, and 0.17, respectively.
Mass and nuclear magnetic resonance
spectra. A Japan Electron Optics Laboratory
HX-100 mass spectrometer (JEOL, Tokyo,
Japan) in electron impact mode was used for
structure analysis of the metabolites. Mass spec-
troscopy was carried out at a collision energy of
70 eV and an acceleration voltage of 10 kV.
Results
Estrogenic activity of TCB and CCB with or
without a microsomal activation system.
Estrogenic activity of TCB and CCB in the
presence or absence of a rat liver microsomal
oxidation system was examined in the YES
assay. These compounds did not show estro-
genic activity in this assay. However, when
TCB was incubated with liver microsomes of
phenobarbital-treated rats in the presence of
NADPH, the extract of the incubation mixture
exhibited an estrogenic effect on the cells in the
range of 10–5 to 10–6 M. In contrast, little effect
was obtained when liver microsomes of
untreated or 3-methylcholanthrene–treated rats
were used instead of those from phenobarbital-
treated rats. CCB showed estrogenic activity
after incubation with the liver microsomes of 3-
methylcholanthrene–treated rats, but the ac-
tivity was much lower than that of TCB
(Figure 2). These estrogenic activities were
inhibited by the addition of tamoxifen at the
concentration of 1 × 10–6 M (data not shown).
Estrogenic activity of 1,3-diphenyl-
propane, 2,4-diphenyl-1-butene, 2,4,6-
triphenyl-1-hexene, and 1α-phenyl-4β-
(1´-phenylethyl)tetralin with or without a
microsomal activation system. 1,3-Diphenyl-
propane, 2,4-diphenyl-1-butene, 2,4,6-
triphenyl-1-hexene, and 1α-phenyl-4β-
(1´-phenylethyl)tetralin were negative in the
YES assay, except for marginal activity at
higher concentrations. However, 1,3-
diphenylpropane exhibited estrogenic activity
after incubation with rat liver in the presence
of microsomes of untreated and 3-methyl-
cholanthrene–treated rats in the presence of
NADPH. Lower activity was observed after
incubation with liver microsomes of pheno-
barbital-treated rats. 2,4-Diphenyl-1-butene
showed estrogenic activity after incubation
with liver microsomes of 3-methylcholan-
threne–treated rats. Little effect was obtained
when liver microsomes of untreated or pheno-
barbital-treated rats were used instead of those
from 3-methylcholanthrene–treated rats. In
contrast, 2,4,6-triphenyl-1-hexene and 1α-
phenyl-4β-(1´-phenylethyl)tetralin did not
show estrogenic activity after similar incuba-
tion (Figure 3).
These facts suggest that some styrene
oligomers, especially TCB, exhibit estrogenic
activity after metabolic activation by rat liver
microsomes.
Metabolism of TCB by rat liver micro-
somes. TCB was incubated with liver micro-
somes of phenobarbital-treated rats in the
presence of NADPH for the detection of the
metabolites as described in “Materials and
Methods.” Three peaks were detected in an
HPLC chromatogram of the extract of the
TCB incubation mixture (Figure 4). These
peaks were not detected in the control,
which was incubated without the substrate.
The metabolites of TCB detected at 7.2,
10.9, and 14.6 min were designated TCB
metabolites 1, 2, and 3 (TD-M1, -M2, and 
-M3), respectively.
Identiﬁcation of estrogenic active metabo-
lites of TCB generated by rat liver microsomes.
After the incubation of TCB with liver micro-
somes of phenobarbital-treated rats in the pres-
ence of NADPH, HPLC fractions were
collected for the identification of the active
metabolites. The fraction corresponding
to TD-M3 exhibited estrogenic activity
(Figure 4). The mass spectrum of TD-M3
showed m/z 196 (M+), suggesting that TD-M3
is a monohydroxylated metabolite of TCB.
The nuclear magnetic resonance spectrum of
TD-M3 showed signals at δ 6.75 (doublet,
2H, J = 8 Hz, phenyl groups), 7.09 (doublet,
2H, J = 8 Hz, phenyl groups), 7.24 (multiplet,
5H, phenyl groups), and 8.00 (singlet, 1H,
OH). The further oxidized metabolite, trans-
1,2-bis-(4-hydroxyphenyl)cyclobutane, could
not be detected by HPLC or thin-layer chro-
matography as a metabolite of TCB. These
facts suggest that TCB is mainly metabolized
to trans-1-(4-hydroxyphenyl)-2-phenylcylo-
butane by rat liver microsomes.
Oxidase activities of rat liver microsomes
toward TCB. The oxidase activity of rat liver
microsomes transforming TCB to TD-M3 was
examined using liver microsomes of phenobar-
bital-treated rats. The time course of formation
of the hydroxylated metabolite was essentially
linear for 10 min (Figure 5A). The oxidase
activity of the liver microsomes increased lin-
early with increasing amount of liver micro-
somes up to 0.5 mg of protein (Figure 5B).
Liver microsomes of phenobarbital-treated rats
exhibited the highest oxidase activity in the
presence of NADPH. The NADPH-linked
activity was inhibited by the addition of SKF
525-A (1 × 10–4 M). Little oxidase activity was
observed when liver microsomes of untreated
or 3-methylcholanthrene–treated rats were used
instead of those of phenobarbital-treated rats
(Figure 5C). Only marginal activity was
observed with reduced nicotinamide adenine
dinucleotide (NADH) instead of NADPH
(data not shown). This suggests that TCB was
mainly metabolized to trans-1-(4-hydroxy-
phenyl)-2-phenylcyclobutane by cytochrome
P450 2B1 in rats.
Estrogenic activity of styrene oligomers in
estrogen reporter assay using MCF-7 cells.
Estrogenic activity of styrene oligomers in the
presence or absence of a rat liver microsomal
oxidation system was also examined by
ERE–luciferase reporter assay using MCF-7
cells. TCB, CCB, 1,3-diphenylpropane, and
2,4-diphenyl-1-butene were negative in this
estrogen screening test, except for a marginal
effect at 1 × 10–5 M. When TCB was incu-
bated with liver microsomes of phenobarbital-
treated rats in the presence of NADPH, the
extract of the incubation mixture exhibited
estrogenic activity at the concentration of
1 × 10–5 M, as in the YES assay. Lower activity
was obtained in this assay when liver micro-
somes of untreated or 3-methylcholan-
threne–treated rats were used instead of those
from phenobarbital-treated rats. In contrast,
CCB showed estrogenic activity after incuba-
tion with the liver microsomes of untreated,
phenobarbital-treated, and 3-methylcholan-
threne–treated rats, but these activities were
lower than that of TCB. 1,3-Diphenylpropane
exhibited estrogenic activity after incubation
with liver microsomes of untreated and 3-
methylcholanthrene–treated rats in the pres-
ence of NADPH. 2,4-Diphenyl-1-butene
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Figure 2. Estrogenic activity of TCB and CCB with or without a rat liver microsomal enzyme system in the
YES assay. Abbreviations: E2, 17β-estradiol; PB, phenobarbital; MC, 3-methylcholanthrene. (A) Estrogenic
activity of TCB. (B) Estrogenic activity of CCB. Each bar represents the mean ± SD of four experiments. TCB
or CCB was incubated with liver microsomes in the presence of NADPH, and the extract of the incubation
mixture was subjected to the screening test.
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CCB (PB-treated)showed estrogenic activity after similar incuba-
tion with liver microsomes of 3-methylcholan-
threne–treated rats (Figure 6). These estrogenic
activities were completely inhibited by the
addition of tamoxifen at the concentration of
1 × 10–6 M (data not shown).
Thus, the results of the estrogen screening
test with MCF-7 cells confirm that some
styrene oligomers exhibit estrogenic activ-
ity after metabolic activation by rat liver
microsomes.
Discussion
Styrene oligomers such as TCB are by-products
in the manufacture of polystyrene and may
later be released from the resin (Kawamura et
al. 1998b; Sakamoto et al. 2000). Nobuhara et
al. (1999) reported that styrene oligomers did
not induce the proliferation of MCF-7 cells.
We also showed in this study that these com-
pounds do not exhibit estrogenic activity in the
YES assay or estrogen screening assay using
MCF-7 cells. However, some of them yield
estrogenic metabolites after metabolic activa-
tion. Ohyama et al. (2001) reported that some
styrene dimers and trimers were estrogenic
without metabolic activation in a cell prolifera-
tion assay with estrogen-responsive MCF-7
cells. They reported that TCB, CCB, 1,3-
diphenylpropane, and 2,4-diphenyl-1-butene
were positive without metabolic activation. We
cannot explain the difference from our present
results. However, one possibility is that because
the substrates were in contact with MCF-7 cells
for a long time in their assay, estrogenic
metabolites were generated in the cells.
We present here the first evidence that
TCB, CCB, 1,3-diphenylpropane, and 2,4-
diphenyl-1-butene are converted to metabolites
with estrogenic activity by liver microsomal
enzymes. It has been reported that some styrene
oligomers do not give a positive response in
uterotrophic assay (Bachmann et al. 1998; Fail
et al. 1998; Prinsen and Gouko 2001).
However, the levels of active metabolites in the
body would be an important factor determin-
ing the effects of the oligomers in vivo. The
apparent afﬁnities of such xenoestrogens for the
estrogen receptor are lower than those of
endogenous estradiol or phytoestrogens.
Nevertheless, endogenous estrogens are tightly
regulated in the body. We speculate that phy-
toestrogens, which are present in foods that
have been consumed from the earliest times,
may also be subject to regulation. This may not
be the case for xenoestrogens, which may act
directly on the endocrine organs. Further,
xenoestrogens may be accumulated in the
body, their intake amounts vary considerably
among consumers, and the amounts released
from polystyrene resin are variable. Styrene
oligomers may exhibit estrogenic activity in
combination with other xenoestrogens. Further
work is necessary to assess the in vivo endocrine-
disrupting action of styrene oligomers, taking
into account the activities of the metabolites
produced from the parent compounds.
We showed in previous reports that trans-
stilbene and trans-stilbene oxide were oxidized
to hydroxylated derivatives by rat liver micro-
somes (Sugihara et al. 2000; Sanoh et al. 2002).
In those studies, we obtained evidence that
trans-stilbene is oxidized to the 4-hydroxy and
4,4´-dihydroxy derivatives by cytochrome P450
1A1/2 in rat liver microsomes and is thereby
activated to exhibit estrogenic activity. In con-
trast, cis-stilbene and cis-stilbene oxide exhibited
only weak estrogenic activity even after meta-
bolic activation. TCB structurally resembles
trans-stilbene and trans-stilbene oxide, and this
may be the reason why its metabolites exhibited
the highest activity among the compounds
tested in this study. As in the case of cis-stilbene
and cis-stilbene oxide, the activities of the cis-
isomers were much lower than those of the
trans-compounds (Sugihara et al. 2000). The
activity of CCB after activation is also lower
than that of the trans-isomer.
We have shown here that trans-1-(4-
hydroxyphenyl)-2-phenylcyclobutane is a
major active metabolite of TCB in a rat liver
microsomal system. Furthermore, formation
of the metabolite was stimulated by the pre-
treatment of rats with phenobarbital. This
suggests that cytochrome P450 2B isoform is
responsible for this activation. In a prelimi-
nary study, when TCB was incubated with
microsomal preparations from cells expressing
recombinant human cytochrome P450 2B6
and rat cytochrome P450 2B1 expressed in a
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Figure 3. Estrogenic activity of 1,3-diphenylpropane, 2,4-diphenyl-1-butene, 2,4,6-triphenyl-1-hexene, and
1α-phenyl-4β-(1´-phenylethyl)tetralin with or without a rat liver microsomal enzyme system in the YES
assay. Abbreviations: E2, 17β-estradiol; PB, phenobarbital; MC, 3-methylcholanthrene. (A) Estrogenic
activity of 1,3-diphenylpropane. (B) Activity of 2,4-diphenyl-1-butene. (C) Activity of 2,4,6-triphenyl-1-hex-
ene. (D) Activity of 1α-phenyl-4β-(1´-phenylethyl)tetralin. Each bar represents the mean ± SD of four
experiments. A styrene oligomer was incubated with liver microsomes in the presence of NADPH, and the
extract of the incubation mixture was subjected to the screening test.
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0human B lymphoblastoid cell line (Gentest
Corp., Woburn, MA, USA), cytochrome P450
2B6 exhibited a higher oxidase activity than did
cytochrome P450 2B1. Significant oxidase
activity was also observed in human liver
microsomes (Gentest Corp.) (data not shown).
Thus, cytochrome P450 isoforms other than
cytochrome P450 2B may contribute to the
metabolic activation in humans. In contrast,
2,4-diphenyl-1-butene was metabolically acti-
vated to an estrogenic derivative by liver micro-
somes of 3-methylcholanthrene–treated rats. In
this case, cytochrome P450 1A may be mainly
responsible for the activation. The oxidation of
2,4-diphenyl-1-butene was catalyzed by rat
cytochrome P450 1A1/2. These isozymes are
also known isoforms of cytochrome P450 in
humans. It is thus possible that metabolic acti-
vation of these styrene oligomers to active estro-
gens occurs in humans. In contrast, activation
of 1,3-diphenylpropane proceeded with liver
microsomes of untreated and 3-methylcholan-
threne–treated rats but not those of phenobar-
bital-treated rats. Possibly, the oxidative
metabolism of 1,3-diphenylpropane by liver
microsomes of phenobarbital-treated rats pref-
erentially generated nonestrogenic metabolites.
It is interesting that different styrene oligomers
are activated by different cytochrome P450 iso-
forms, and the potencies of estrogenic activity
of the metabolites formed are different.
A possible metabolic activation pathway
of proestrogenic TCB and CCB with liver
microsomes is shown in Figure 7. TCB is
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Figure 5. Oxidase activities of rat liver microsomes toward TCB. (A) Time course of the oxidase activity. (B)
Liver microsome dependency of the reaction. (C) Oxidase activity of liver microsomes from untreated, phe-
nobarbital (PB)-treated, and 3-methylcholanthrene (MC)–treated rats. Each value represents the mean ±
SD of four rats. A mixture containing 0.1 µmol of TCB, 0.5 µmol of NADPH, and 20 µL of liver microsomes,
except in (B), for which 0.1 M phosphate buffer (pH 7.4) was used, was incubated at 37°C for 20 min except
in (A). Inhibitors were added at the concentration of 10–4 M. The trans-1-(4-hydroxyphenyl)-2-phenylcy-
clobutane formed was determined using HPLC as described in “Materials and Methods.”
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Figure 6. Estrogenic activity of styrene oligomers with or without a rat liver microsomal enzyme system
using ERE–luciferase reporter assay in MCF-7 cells. Abbreviations: PB, phenobarbital; MC, 3-methylcholan-
threne. (A) Estrogenic activity of TCB. (B) Activity of CCB. (C) Activity of 1,3-diphenylpropane. (D) Activity of
2,4-diphenyl-1-butene. Each bar represents the mean ± SD of four experiments. Estrogenic activity was
expressed as a relative activity with respect to the control using MCF-7 cells.
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Figure 7. Proposed metabolic pathways for the activation of TCB and CCB in rats. CYP, cytochrome P450.
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Figure 4. HPLC of the extract of an incubation
mixture of TCB with rat liver microsomes, and
estrogenic activity of each fraction in the YES
assay. (A) HPLC chromatogram of the metabolites
of TCB. (B) Estrogenic activity of each fraction in
the YES assay. An incubation mixture consisting of
0.1 µmol of TCB, 0.5 µmol of NADPH, and 20 µL of
liver microsomes was incubated for 10 min. The
extract of the mixture with ethyl acetate was ana-
lyzed by HPLC, and the eluate was collected at
5-min intervals for the YES assay.
A
0.2
0.1
0
0
–
5
5
–
1
0
1
0
–
1
5
1
5
–
2
0
2
0
–
2
5
2
5
–
3
0
3
0
–
3
5
3
5
–
4
0
4
0
–
4
5
4
5
–
5
0
5
0
–
5
5
5
5
–
6
0
6
0
–
6
5
6
5
–
7
0
Time (min)
N
e
t
 
O
D
5
4
0
TD-M1
TCB
TD-M2
TD-M3 Internal standard
Bconverted to hydroxylated derivatives by rat
liver microsomes (pathways 1 and 2). In the
microsomal system used in this study, the
estrogenic activity of TCB is thought to be
mainly exhibited by trans-1-(4-hydroxy-
phenyl)-2-phenylcyclobutane, because path-
way 2 does not proceed effectively in this
system. The further oxidized metabolite of
trans-1-(4-hydroxyphenyl)-2-phenylcyclo-
butane, trans-1,2-bis-(4-hydroxyphenyl)cyclo-
butane, could not be detected. In contrast,
CCB is thought to be metabolized to the cor-
responding hydroxylated metabolites with liver
microsomes. However, the activity of CCB
after metabolic activation was lower than that
of the trans-isomer. cis-1-(4-Hydroxyphenyl)-
2-phenylcyclobutane may exhibit lower estro-
genic activity than the trans-isomer. The
activity of CCB after metabolic activation may
be due to trans-1-(4-hydroxyphenyl)-2-phenyl-
cyclobutane formed after cis–trans isomeriza-
tion (i.e., pathway 3). In our preliminary
study, when CCB was incubated with liver
microsomes without NADPH, a peak corre-
sponding to TCB was detected by HPLC. The
2- or 3-hydroxylated metabolite of TCB may
also be formed. However, relatively high activ-
ity was exhibited only by TD-M3 among the
metabolites generated in the present oxidase
system, as shown in Figure 4.
There are various other examples of
metabolic activation to an estrogen, besides
that of trans-stilbene. p,p´-DDT is metabo-
lized to p,p´-DDD and p,p´-DDE (p,p´-
dichlorodiphenyldichloroethylene) by
reductive dechlorination and dehydrochlori-
nation, respectively (Esaac and Matsumura
1980; Kitamura et al. 2002). p,p´-DDD
shows estrogenic activity and p,p´-DDE
shows antiandrogenic activity (Kelce et al.
1995; Chen et al. 1997). Further, methoxy-
chlor is a proestrogen that requires demethy-
lation by liver microsomal mixed function
oxidase in animals before eliciting estrogenic
activity (Kupfer and Bulger 1987; Stresser
and Kupfer 1998). It is known that PCBs are
converted to hydroxylated metabolites in
animals (Koga et al. 1990). Some hydroxy-
lated PCBs show estrogenic activity (Korach
et al. 1988; Connor et al. 1997; Garner et al.
1999). p-Hydroxybenzophenone, which is
formed from benzophenone, an antifungal
agent, in rat hepatocytes, is also estrogenic
(Nakagawa and Tayama 2001; Nakagawa
and Suzuki 2002). Hydroxylated metabolites
of benzo[a]pyrene also exhibit estrogenic activ-
ity (Charles et al. 2000; Fertuck et al. 2001).
Elsby et al. (2000, 2001) predicted estrogenic-
ity by a two-stage approach coupling human
liver microsomes and a yeast estrogenicity
assay. Methoxychlor, methoxybisphenol A,
and 3,17β bisdesoxyestradiol were positive,
but 6-hydroxytetralin was negative, in this
screening system. Much further work is
needed to identify potentially hazardous
proestrogens in our environment.
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